Cowen Downgrades Aegerion Pharmaceuticals (AEGR) to Market Perform
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Price: $1.97 --0%
Rating Summary:
8 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Rating Summary:
8 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Join SI Premium – FREE
Cowen downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Outperform to Market Perform with a price target of $36.00 (from $85).
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $44.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- Five Below (FIVE) PT Raised to $273 at Truist Securities
- Nintendo Co Ltd. (7974:JP) (NTDOY) PT Raised to JPY10,000 at Benchmark
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
